+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmacogenomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Technology, By Service, By Application, By End User, By Region

  • PDF Icon

    Report

  • 114 Pages
  • August 2023
  • Region: Global
  • TechSci Research
  • ID: 5852942
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global pharmacogenomics market is expected to grow at a robust rate during the forecast period. This can be ascribed to the growing popularity and adoption of personalized medicine in the field of healthcare. Pharmacogenomics studies the way a patient’s DNA affects the way his/her body responds to drugs. The growing prevalence of various chronic diseases such as cancer, cardiovascular diseases, respiratory ailments, and renal disorders, among others, has significantly increased the demand for developing personalized treatments for the treatment of these diseases, thereby driving the growth of global pharmacogenomics market. Additionally, increasing research & development activities along with various companies entering the personalized medicine space is expected to create lucrative opportunities for the growth of global pharmacogenomics market. For instance, in June 2020, Infosys Limited launched personalized medicine solutions for the pharmaceutical industry to digitally transform their processes and drive stronger business outcomes.

Increasing Rate of Adverse Drug Reaction

Adverse Drug Reactions (ADRs) include medication-related side effects that develop during clinical use. Furthermore, they can continue for a long time, decreasing a patient's quality of life. ADRs can cause morbidity and fatality in severe circumstances. The increasing number of medications on the market and the rapid rise of polypharmacy to treat different disorders, especially in the elderly population, among others, are all contributing to the global occurrence of ADRs. The fast growth in the number of ADR cases is driving the demand for more effective treatment regimens. Precision medicine and pharmacogenomics offer a feasible answer to this problem by identifying patients who require specific therapeutic modules that will give good therapy while reducing/eliminating the possibility of any ADR. With established attempts to address such important problems, the global pharmacogenomics market growth is expected to witness significant growth in the coming years.

Increasing Research & Development Activities

The growing research & development activities for developing treatments and drugs, taking into consideration the genetic makeup and effect of environment and surroundings on human health, are expected to create lucrative opportunities for market growth through 2027. Precision medicine or personalized medicine forms the basis of pharmacogenomics; the growing adoption and demand for personalized medicine are further expected to support the growth of global pharmacogenomics. Additionally, biotechnology & pharmaceutical companies and academic & research institutions worldwide are making investments, increasing their research & development funds and related activities, and conducting clinical trials, among others related to pharmacogenomics, thereby creating opportunities for market growth in the coming years. For instance, according to a report published by the National Institute of Health of the United States in May 2022, the expenditure on research & development activities related to cancer genomics increased from USD861 million in 2016 to USD1,220 million in 2022. Similarly, the research and development activities related to personalized medicines are increasing across other parts of the globe also. For instance, in October 2021, the Israel Precision Medicine Partnership (IPMP) awarded funding of about USD 9.9 million to 11 projects in Israel for the research of personalized medicine that includes cancers, Crohn’s disease, and rare diseases.

Market Segmentation

The global pharmacogenomics market can be segmented by technology, service, application, end-user, by region. Based on technology, the market can be categorized into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. Based on service, the market can be fragmented into genotyping, SNP identification, pharmacogenetic testing, and others. Based on application, the market can be grouped into drug discovery, oncology, neurology and psychiatry, pain management, cardiovascular diseases, and others. Based on end-user, the market can be classified into hospitals & clinics, biotechnology & pharmaceutical companies, and others. Regionally, North America dominated the market among Europe, Asia Pacific, Middle East & Africa, and South America. The United States dominated the pharmacogenomics market among all the countries globally on account of increasing research and development activities in the country. In 2022, the revenue in scientific research & development is projected to reach USD8.11 billion in the United States.

Market Players

Abbott Laboratories, Inc., Illumina, Inc., Thermo Fischer Scientific, Inc., AstraZeneca Plc., F.Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Eurofins Scientific SE, Pacific Biosciences of California Inc., Qiagen N.V., PerkinElmer, Inc., Oxford Nanopore Technologies Limited, Agilent Technologies, Inc., Myriad Genetics, Inc, Admera Health, LLC are some of the leading players operating in the global pharmacogenomics market.

Report Scope:

In this report, global pharmacogenomics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Pharmacogenomics Market, By Technology:

  • PCR
  • Sequencing
  • Microarray
  • Gel Electrophoresis
  • Mass Spectrometry
  • Others

Pharmacogenomics Market, By Service:

  • Genotyping
  • SNP Identification
  • Pharmacogenetic Testing
  • Others

Pharmacogenomics Market, By Application:

  • Drug Discovery
  • Oncology
  • Neurology and Psychiatry
  • Pain Management
  • Cardiovascular Diseases
  • Others

Pharmacogenomics Market, By End User:

  • Hospitals & Clinics
  • Biotechnology & Pharmaceutical Companies
  • Others

Pharmacogenomics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global pharmacogenomics market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on Global Pharmacogenomics Market5. Voice of Customer
6. Global Pharmacogenomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, Others)
6.2.2. By Service (Genotyping, SNP Identification, Pharmacogenetic Testing, Others)
6.2.3. By Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, Others)
6.2.4. By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Pharmacogenomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Service
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Pharmacogenomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Service
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Canada Pharmacogenomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Service
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Mexico Pharmacogenomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Service
7.3.3.2.3. By Application
7.3.3.2.4. By End User
8. Europe Pharmacogenomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Service
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Pharmacogenomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Service
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. Germany Pharmacogenomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Service
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. United Kingdom Pharmacogenomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Service
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Italy Pharmacogenomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Service
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Spain Pharmacogenomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Service
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Asia Pacific Pharmacogenomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Service
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Pharmacogenomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Service
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. India Pharmacogenomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Service
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Japan Pharmacogenomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Service
9.3.3.2.3. By Application
9.3.3.2.4. By End User
9.3.4. South Korea Pharmacogenomics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Technology
9.3.4.2.2. By Service
9.3.4.2.3. By Application
9.3.4.2.4. By End User
9.3.5. Australia Pharmacogenomics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Technology
9.3.5.2.2. By Service
9.3.5.2.3. By Application
9.3.5.2.4. By End User
10. South America Pharmacogenomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Service
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Pharmacogenomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Service
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Argentina Pharmacogenomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Service
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Colombia Pharmacogenomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Service
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Middle East and Africa Pharmacogenomics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Technology
11.2.2. By Service
11.2.3. By Application
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Pharmacogenomics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Technology
11.3.1.2.2. By Service
11.3.1.2.3. By Application
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Pharmacogenomics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Technology
11.3.2.2.2. By Service
11.3.2.2.3. By Application
11.3.2.2.4. By End User
11.3.3. UAE Pharmacogenomics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Technology
11.3.3.2.2. By Service
11.3.3.2.3. By Application
11.3.3.2.4. By End User
11.3.4. Egypt Pharmacogenomics Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Technology
11.3.4.2.2. By Service
11.3.4.2.3. By Application
11.3.4.2.4. By End User
11.3.5. Turkey Pharmacogenomics Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Technology
11.3.5.2.2. By Service
11.3.5.2.3. By Application
11.3.5.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Abbott Laboratories, Inc.
14.2. Illumina, Inc.
14.3. Thermo Fischer Scientific, Inc.
14.4. AstraZeneca Plc.
14.5. F.Hoffmann-La Roche AG
14.6. Bio-Rad Laboratories, Inc.
14.7. Becton, Dickinson and Company
14.8. Eurofins Scientific SE
14.9. Pacific Biosciences of California Inc.
14.10. Qiagen N.V.
14.11. PerkinElmer, Inc.
14.12. Oxford Nanopore Technologies Limited
14.13. Agilent Technologies, Inc.
14.14. Myriad Genetics, Inc
14.15. Admera Health, LLC
15. Strategic Recommendations

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Illumina, Inc.
  • Thermo Fischer Scientific, Inc.
  • AstraZeneca Plc.
  • F.Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Eurofins Scientific SE
  • Pacific Biosciences of California Inc.
  • Qiagen N.V.
  • PerkinElmer, Inc.
  • Oxford Nanopore Technologies Limited
  • Agilent Technologies, Inc.
  • Myriad Genetics, Inc
  • Admera Health, LLC

Related Topics

Related Reports

Global Pharmacogenomics Market by Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic) - Forecast to 2031 - Product Image

Global Pharmacogenomics Market by Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic) - Forecast to 2031

  • Report
  • 210 Pages
  • Global
From
Pharmacogenomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Pharmacogenomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Pharmacogenomics Global Market Report 2024 - Product Image

Pharmacogenomics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Pharmacogenomics Market Report by Technology, Application, End User, and Region 2024-2032 - Product Image

Pharmacogenomics Market Report by Technology, Application, End User, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Forecast to 2028 - Product Image

Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Forecast to 2028

  • Report
  • 381 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.